| Patient’ characteristics | Disease outcome after intervention | |||||||||||
| Patient | Age (years) | Sex | Duration of disease (years) | Treatment history | Complications | Period of intervention | Disease arrest | Boarder blurring | Repigmentation | Assinged site | Adverse effect | Period of follow up |
| 1 | 68 | M | 20 | Topical corticosteroid vitamin D3 | N.P. | Aug. to Mar. | No | No | No | Back of neck | N.P. | 1 year 4 months |
| 2 | 17 | M | 5 | Topical corticosteroid tacrolimus vitamin D3 | N.P. | Aug. to Apr. | No | No | Follicular repigmentation but recurrented | Left forearm, right lower leg | N.P. | 1 year 4 months |
| 3 | 71 | F | 35 | Topical corticosteroid vitamin D3 oral corticosteroid | Sjögren’s syndrome | Dec. to Mar. | Yes | Yes | Peripheral repigmentation | Each cheek, fprehead | Temporal insomnia | 1 year 3 months |
| 4 | 71 | M | 2 | Topical corticosteroid vitamin D3 UV | N.P. | Nov. to Jan. | Yes | Yes | Peripheral repigmentation | Left lower abdomen, left lower leg | Temporal insomnia | 1 year 4 months |
| 5 | 64 | F | 4 | Topical corticosteroid UV | N.P. | Apr. to Jan. | Yes | Excellent | Peripheral repigmentation | Back of neck, anterior chest | Temporal insomnia | 2 year 3 month |